SenzaGen

SenzaGen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD^® sensitization test through its own laboratory and through licensed CROs.

As a scientific quality-orientated and innovative international company, SenzaGen supports its clients with stringent quality assessments. The GARD^® test is recommended by ECHA and accepted by OECD for validation.

SenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes.